Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Elter

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximabJ Boye, T Elter, A Engert
Journal of the American College of Cardiology|October 5, 2001
Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failureC Maack, T Elter, G Nickenig, et al.
Leukemia|October 8, 2011
Phase 1b trial of atacicept, a recombinant protein binding BLyS and APRIL, in patients with chronic lymphocytic leukemiaD M Kofler, B B Gawlik, T Elter, et al.
Fortschritte Der Neurologie-Psychiatrie|September 2, 2015
[Chemotherapy-induced Peripheral Neuropathy]I Bobylev, T Elter, C Schneider, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 2, 2018
Sensorimotor training and whole-body vibration training have the potential to reduce motor and sensory symptoms of chemotherapy-induced peripheral neuropathy-a randomized controlled pilot trialFiona Streckmann, H C Lehmann, M Balke, et al.
Contemporary Clinical Trials|June 5, 2016
Impact of aerobic exercise training during chemotherapy on cancer related cognitive impairments in patients suffering from acute myeloid leukemia or myelodysplastic syndrome - Study protocol of a randomized placebo-controlled trialP Zimmer, M Oberste, W Bloch, et al.
Leukemia|May 16, 2012
Fludarabine and cyclophosphamide in combination with alemtuzumab in patients with primary high-risk, relapsed or refractory chronic lymphocytic leukemiaT Elter, R James, R Busch, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximabJ Boye, T Elter, A Engert
Journal of the American College of Cardiology|October 5, 2001
Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failureC Maack, T Elter, G Nickenig, et al.
Leukemia|October 8, 2011
Phase 1b trial of atacicept, a recombinant protein binding BLyS and APRIL, in patients with chronic lymphocytic leukemiaD M Kofler, B B Gawlik, T Elter, et al.
Fortschritte Der Neurologie-Psychiatrie|September 2, 2015
[Chemotherapy-induced Peripheral Neuropathy]I Bobylev, T Elter, C Schneider, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 2, 2018
Sensorimotor training and whole-body vibration training have the potential to reduce motor and sensory symptoms of chemotherapy-induced peripheral neuropathy-a randomized controlled pilot trialFiona Streckmann, H C Lehmann, M Balke, et al.
Contemporary Clinical Trials|June 5, 2016
Impact of aerobic exercise training during chemotherapy on cancer related cognitive impairments in patients suffering from acute myeloid leukemia or myelodysplastic syndrome - Study protocol of a randomized placebo-controlled trialP Zimmer, M Oberste, W Bloch, et al.
Leukemia|May 16, 2012
Fludarabine and cyclophosphamide in combination with alemtuzumab in patients with primary high-risk, relapsed or refractory chronic lymphocytic leukemiaT Elter, R James, R Busch, et al.
Pageof 1